Yubo Biotech Operating Income 2010-2024 | YBGJ

Yubo Biotech operating income from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.

Yubo Biotech Operating Income 2010-2024 | YBGJ

Yubo Biotech operating income from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$209.2B
Intuitive Surgical (ISRG)$190.8B
Alcon (ALC)$45.5B
IQVIA Holdings (IQV)$39.4B
Edwards Lifesciences (EW)$39.3B
IDEXX Laboratories (IDXX)$35.8B
DexCom (DXCM)$27.5B
Waters (WAT)$22.6B
SONOVA HOLDING (SONVY)$22.1B
STERIS (STE)$21.9B
Hologic (HOLX)$18.4B
Sysmex ADR (SSMXY)$12.9B
Fresenius Medical Care AG KGaA (FMS)$12.6B
Globus Medical (GMED)$11.1B
Penumbra (PEN)$9.3B
Teleflex (TFX)$9.2B
Masimo (MASI)$8.7B
Glaukos (GKOS)$7.9B
PROCEPT BioRobotics (PRCT)$5.1B
Integer Holdings (ITGR)$4.7B
Inari Medical (NARI)$3.1B
Veracyte (VCYT)$3B
TransMedics (TMDX)$3B
LivaNova (LIVN)$2.8B
Nihon Kohden (NHNKY)$2.6B
Elekta AB (EKTAY)$2.3B
Tandem Diabetes Care (TNDM)$2.1B
Integra LifeSciences Holdings (IART)$2B
RxSight (RXST)$1.9B
Alphatec Holdings (ATEC)$1.4B